NH3 Jobs

Executive Director, Engineering (FLEx Co-Lead)

Merck
MerckRahway, NJ3d ago
Full timeFull timeExecutive

Compensation

Estimated
Est. $35–$49/hr
Certifications
Estimated
CMRP (preferred)
Equipment
Estimated
CMMS SoftwareBuilding Systems
Functions
Estimated
Team LeadershipBudget ManagementMaintenance Planning

The Role

Job Description FLEx is a set of multi-modality Drug Product development and GMP clinical manufacturing assets constructed in the Rahway, New Jersey site, to support our company’s diverse and growing pipeline of oral and injectable therapeutics and vaccine drug products. Operational leadership of the FLEx complex is shared across three Executive Director roles, and includes operations in RY buildings 53, 119, 880 and 80B that support end-to-end GMP clinical supply manufacture and product/process development, as well as oversight of Enterprise Resource Planning systems (SAP, PAS-x), the Drug Product Quality Management System (QMS) and the Data Analytics platforms that support the areas. Facilities in RY119, RY53, RY80B and RY880 have been operational since 2023 and currently run a 5-day, 2-shift operating schedule. However, operating schedule may change over time based on pipeline need (eg. Move to a 7-day, 24-hour schedule). Aligned with the design intent of FLEx, the plant is in a state of significant growth as the result of pipeline expansion and adoption of Launch Preparedness approaches. Significant capital investment is proceeding in both the sterile and non-sterile modalities. It is expected that this level of change to both footprint and installed capability will continue as our company s Research Labs sees pipeline shifts. Being able to adeptly forecast and deliver new technology elements in a manner which adheres to budgetary and timeline commitments and is least disruptive to continued operations is a key responsibility of FLEx Lead role. The three FLEx Co-Lead roles are jointly accountable for all activities associated with FLEx, including the realization of the overall FLEx intent in the Pharmaceutical Sciences and Device Development (PSDD) organization. This includes operating model, culture, talent development, technology introduction, process/product development and compliance. To ensure success, each of the FLEx co-leads is focused on a different part of the infrastructure and set of products/modalities. The current opening is for FLEx Sterile 2 and is focused on the new Optima sterile filling installation which is scheduled to be Ready-For-Science in early 2030. The FLEx 2 Sterile suites contains a highly integrated and state-of-the-art sterile formulation and filling suite with a full complement of sterile support equipment systems (eg. DHO, Autoclave), capable of processing highly potent and higher-level biosafety pharmaceuticals and vaccines, to support pre-clinical through late-phase manufacture. The equipment is highly dependent on robotic operations and novel containment systems for worker safety and sterility assurance. Ensuring FLEx is positioned to deliver clinical supply for speed to FIH and clinical development, and to answer the critical research problem statements required for successful commercial launch is the responsibility of the FLEx Sterile Lead. Understanding scaling between lab, pilot plant and our company s manufacturing division commercial sterile filling lines is a critical skillset of the FLEx Sterile Co-Lead. Equally important is an understanding of the pipeline and ability to direct the right programs into FLEx, to optimize utilization and best leverage internal capability on high value assets. Within each modality, the FLEx Co-Lead is responsible for providing tactical and strategic level direction to the cross-functional program teams working in the FLEx assets across RY880, RY53, RY53 and RY80B. This extends from materials management, GMP manufacture, formulation development, and bulk Drug Product release. Close connectivity with upstream Drug Substance and downstream packaging partners is required to optimally support clinical development and product commercialization. The FLEx Co-Lead oversees performance management processes that govern operations, tier, clinical siting and global compliance councils. Key performance indicators range from quality and regulatory compliance, operational excellence, pipeline program progression, financial, talent development and culture. Key to the realization of the FLEx vision is the creation of a collaborative scientific community that inspires innovation and enables speed of new product development from clinical research to commercialization of robustly understood products and processes. Each FLEx Co-Lead has direct management responsibilities for a staff that is expected to grow to 100 full-time employees plus a large population of GMP service providing contractors. There is an additional matrixed reporting relationship to functional groups in development, quality, safety, facilities management, analytical, finance and regulatory. As noted, FLEx is designed to be a facility that evolves to meet company and pipeline needs over its lifespan. FLEx Co-Leads are responsible for understanding the external and internal drivers of change, translating that FLEx strategy, securing support for that strategy with partners and our comp

Benefits

Estimated
  • Competitive salary
  • Health, dental & vision insurance
  • 401(k) with match
  • Paid time off
  • Bonus potential